Amikacin Liposomal Inhalation Suspension for Non-Tuberculous <i>Mycobacteria</i> Lung Infection: A Greek Observational Study
<i>Background and Objectives:</i> Intravenous amikacin, recommended for severe or recurrent <i>M. avium complex</i> (MAC) infections and as initial treatment for <i>M. abscessus</i> lung disease, is often limited by serious adverse effects such as renal and audito...
| Published in: | Medicina |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/10/1620 |
